TZIELD

TEPLIZUMAB-MZWV · Provention Bio, Inc.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for TZIELD, covering 2022-11-17 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes [Phase 3]

See pricing